Related Experiment Videos
[Drug treatment of heart insufficiency]
1Departement Innere Medizin, Kantonsspital Basel.
Insights
Diuretics offer symptomatic relief for congestive heart failure (CHF) patients. ACE inhibitors are preferred for long-term management of severe CHF due to improved prognosis.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Congestive heart failure (CHF) management involves various drug classes.
- Treatment strategies must balance hemodynamic effects with patient outcomes.
Purpose:
- To review and discuss the optimal drug choices for different forms and stages of CHF.
- To evaluate the efficacy and long-term utility of various therapeutic agents.
Summary:
- Diuretics improve symptoms by reducing ventricular filling pressures but can decrease cardiac output.
- Digoxin offers hemodynamic benefits in advanced CHF with sinus rhythm, though less effective than vasodilators.
- ACE inhibitors are recommended for chronic severe CHF due to sustained efficacy and improved prognosis; newer inotropes show short-term promise but long-term utility is uncertain.
Impact:
- Provides guidance on selecting appropriate pharmacotherapy for congestive heart failure.
- Highlights the importance of long-term treatment strategies and prognosis in CHF management.
Abstract:
Patients with congestive heart failure (CHF) can be treated by diuretics, inotropic agents and vasodilators. Increased diuresis lowers left and right ventricular filling pressures but may further reduce cardiac output. Nevertheless, diuretics produce symptomatic improvement in most patients. Digoxin also has beneficial hemodynamic effects in patients with advanced CHF and sinus rhythm, but the frequency and degree of therapeutic response is inferior to that of vasodilators. Among the latter, ACE inhibitors are the most appropriate for long-term administration since they do not lead to development of tolerance and seem to improve long-term prognosis in patients with severe CHF. Newer inotropic agents have marked hemodynamic effects in the short term, but their utility for chronic treatment remains questionable. The optimum choice of drugs in various forms and stages of CHF is discussed.